Wikipedia -WSS

Wikipedia

author：knowledge 2025-10-01 14:19:57 - browse：499

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： At ASCO, AstraZeneca reports strong data for breast cancer drug

WSS

Apellis safety probe of eye disease drug centers on injection needle

Diversity in medical illustrations gets boost from Chidiebere Ibe

FDA panel gives mixed vote on blood pressure devices

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

ASCO: Palliative care found as helpful given virtually as in person

Ionis drug prevents swelling attacks due to hereditary angioedema

explore

Wikipedia

hotspot

Apple is now the first public company to be valued at $3 trillion

Cord blood banking comes at a high cost to babies

Duchenne breakthrough therapy leaves behind pioneering families

The Pandemic Treaty must support building strong health systems

Malaria cases in Florida and Texas: Here’s what you need to know

The Pandemic Treaty must support building strong health systems

Supreme Court strikes down use of affirmative action

Neuroscience startup Neumora files for IPO

Novavax promises a turnaround & Lilly roils the obesity market

Letters to First Opinion on caregivers, digital health, and more

focus

What AAP's gender

Diversity in medical illustrations gets boost from Chidiebere Ibe

Ionis drug prevents swelling attacks due to hereditary angioedema

2024 GOP presidential candidates spar over abortion in debate

Study finds new variant for Parkinson’s in African populations

FDA's Pazdur wants cancer trials to range beyond China alone

explore

Wikipedia

leisure time

leisure time